Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

New HHS rule would harmonise substance abuse privacy rule, HIPAA

Owkin taps Linux Foundation to open-source its AI learning software

AstraZeneca, C4XD sign exclusive $402 million global licence

Exploring a united vision for British pharma at Anthropy – the pharmaphorum podcast

How automation can help to address supply chain challenges in pharma

Bioniz

eqillium_logo

News/ News/ R&D

Equillium triples clinical pipeline with $329m Bioniz takeover

Phil Taylor alopecia, Bioniz, coeliac disease, Equillium, graft versus host disease, immunology, lymphoma, M&A 0 Comment

Equillium has announced another bolt-on deal to expand its pipeline tripling the size of its clinical pipeline to

X

Equillium triples clinical pipeline with $329m Bioniz takeover

https://pharmaphorum.com/news/equillium-triples-clinical-pipeline-with-329m-bioniz-takeover/

almirall

News/ News/ Oncology

Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1

Richard Staines Almirall, Bioniz, cancer, M&A, skin cancer 0 Comment

Almirall has begun an option agreement with California’s Bioniz, which could see it buy the entire company and

X

Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1

https://pharmaphorum.com/news/almirall-strikes-option-deal-to-buy-bioniz-and-dermatology-drug-bnz-1/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

MHRA, NHS England make available new prostate cancer treatment
Genomic testing 'should be offered to all cancer patients in Scotland'
AstraZeneca, C4XD sign exclusive $402 million global licence
Owkin taps Linux Foundation to open-source its AI learning software
New HHS rule would harmonise substance abuse privacy rule, HIPAA

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com